# FDA Inspection 1065418 - Boiron - June 19, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/boiron/94e1b8a6-1550-4e04-99e7-90f73598de8b
Source feed: FDA_Inspections

> FDA Inspection 1065418 for Boiron on June 19, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1065418
- Company Name: Boiron
- Inspection Date: 2018-06-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255607 - 2024-11-29](https://www.globalkeysolutions.net/records/fda_inspections/boiron/0c040d58-f616-4643-937e-a403e7b55d6d)
- [FDA Inspection 912269 - 2015-01-30](https://www.globalkeysolutions.net/records/fda_inspections/boiron/af97f3ec-2af2-4b41-bab8-e09b4cf9f363)

Company: https://www.globalkeysolutions.net/companies/boiron/5a72b640-7ab9-4ece-a38b-c0a90542739a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c